Dysregulation of Gene Expression Within the Peroxisome Proliferator Activated Receptor Pathway in Morbidly Obese Patients

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2008 Oct 16

PMID 18855061

Citations 7

Authors

A Katharine Hindle

Jadd Koury

Tim McCaffrey

Sidney W Fu

Fred Brody

Affiliations

Soon will be listed here.

Abstract

Background: The causes of obesity are multifactorial but may include dysregulation of a family of related genes, such as the peroxisome proliferator activated receptor gamma (PPARgamma). When activated, the PPARgamma pathway promotes lipid metabolism. This study used microarray technology to evaluate differential gene expression profiles in obese patients undergoing bariatric surgery.

Methods: The study enrolled six morbidly obese patients with a body mass index (BMI) exceeding 35 and four nonobese individuals. Blood samples were stabilized in PaxGene tubes (PreAnalytiX), and total RNA was extracted. Next, 100 ng of total RNA was amplified and labeled using the Ovation RNA Amplification System V2 with the Ovation whole-blood reagent (NuGen) before it was hybridized to an Affymetrix (Santa Clara, CA) focus array containing more than 8,500 verified genes. The data were analyzed using an analysis of variance (ANOVA) (p < 0.05) in the GeneSpring program, and potential pathways were identified with the Ingenuity program. Real-time quantitative reverse transcriptase-polymerase chain reaction was used to validate the array data.

Results: A total of 97 upregulated genes and 125 downregulated genes were identified. More than a 1.5-fold change was identified between the morbidly obese patients and the control subjects for a cluster of dysregulated genes involving pathways regulating cell metabolism and lipid formation. Specifically, the PPARgamma pathway showed a plethora of dysregulated genes including tumor necrosis factor-alpha (TNFalpha). In morbidly obese patients, TNFalpha expression was increased (upregulated) 1.6-fold. These findings were confirmed using quantitative polymerase chain reaction with a 2.8-fold change.

Conclusions: Microarrays are a powerful tool for identifying biomarkers indicating morbid obesity by analyzing differential gene expression profiles. This study confirms the association of PPARgamma with morbid obesity. Also, these findings in blood support previous work documented in tissue (omentum, liver, and stomach). Based on these findings in blood, the authors plan to explore postoperative changes in gene expression by analyzing blood samples after bariatric surgery. Ultimately, these findings may promote the development of therapeutic agents targeted to specific dysfunctional genes.

Citing Articles

Linseed oil supplementation affects fatty acid desaturase 2, peroxisome proliferator activated receptor gamma, and insulin-like growth factor 1 gene expression in turkeys (Meleagris gallopavo).

Szalai K, Tempfli K, Zsedely E, Lakatos E, Gaspardy A, Bali Papp A Anim Biosci. 2020; 34(4):662-669.

PMID: 32810939 PMC: 7961277. DOI: 10.5713/ajas.20.0030.

Neutrophil elastase and myeloperoxidase mRNA expression in overweight and obese subjects.

Ali M, Jasmin S, Fariduddin M, Alam S, Arslan M, Biswas S Mol Biol Rep. 2018; 45(5):1245-1252.

PMID: 30056589 DOI: 10.1007/s11033-018-4279-4.

Changes in Global Transcriptional Profiling of Women Following Obesity Surgery Bypass.

Augusta de Souza Pinhel M, Noronha N, Nicoletti C, de Oliveira B, Cortes-Oliveira C, Pinhanelli V Obes Surg. 2017; 28(1):176-186.

PMID: 28735374 DOI: 10.1007/s11695-017-2828-x.

Obesity is associated with more activated neutrophils in African American male youth.

Xu X, Su S, Barnes V, de Miguel C, Ownby D, Pollock J Int J Obes (Lond). 2014; 39(1):26-32.

PMID: 25388404 PMC: 4286492. DOI: 10.1038/ijo.2014.194.

Suppression of endogenous PPARγ increases vulnerability to methamphetamine-induced injury in mouse nigrostriatal dopaminergic pathway.

Yu S, Airavaara M, Shen H, Chou J, Harvey B, Wang Y Psychopharmacology (Berl). 2011; 221(3):479-92.

PMID: 22160138 PMC: 3351577. DOI: 10.1007/s00213-011-2595-7.

References

Wang Y, Lee C, Tiep S, Yu R, Ham J, Kang H . Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell. 2003; 113(2):159-70. DOI: 10.1016/s0092-8674(03)00269-1. View

Jeffery I, Higgins D, Culhane A . Comparison and evaluation of methods for generating differentially expressed gene lists from microarray data. BMC Bioinformatics. 2006; 7:359. PMC: 1544358. DOI: 10.1186/1471-2105-7-359. View

Grimble R . Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab Care. 2002; 5(5):551-9. DOI: 10.1097/00075197-200209000-00015. View

Vanden Heuvel J . The PPAR resource page. Biochim Biophys Acta. 2007; 1771(8):1108-12. DOI: 10.1016/j.bbalip.2007.03.007. View

Kersten S, Desvergne B, Wahli W . Roles of PPARs in health and disease. Nature. 2000; 405(6785):421-4. DOI: 10.1038/35013000. View

Mokdad A, Ford E, Bowman B, Dietz W, Vinicor F, Bales V . Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2002; 289(1):76-9. DOI: 10.1001/jama.289.1.76. View

Mokdad A, Marks J, Stroup D, Gerberding J . Actual causes of death in the United States, 2000. JAMA. 2004; 291(10):1238-45. DOI: 10.1001/jama.291.10.1238. View

Wilding J . The importance of free fatty acids in the development of Type 2 diabetes. Diabet Med. 2007; 24(9):934-45. DOI: 10.1111/j.1464-5491.2007.02186.x. View

MacLaren R, Cui W, Simard S, Cianflone K . Influence of obesity and insulin sensitivity on insulin signaling genes in human omental and subcutaneous adipose tissue. J Lipid Res. 2007; 49(2):308-23. DOI: 10.1194/jlr.M700199-JLR200. View

10.

Buchwald H, Avidor Y, Braunwald E, Jensen M, Pories W, Fahrbach K . Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004; 292(14):1724-37. DOI: 10.1001/jama.292.14.1724. View

11.

Evans R, Barish G, Wang Y . PPARs and the complex journey to obesity. Nat Med. 2004; 10(4):355-61. DOI: 10.1038/nm1025. View

12.

Ogden C, Yanovski S, Carroll M, Flegal K . The epidemiology of obesity. Gastroenterology. 2007; 132(6):2087-102. DOI: 10.1053/j.gastro.2007.03.052. View

13.

. Annual meeting of the North American Association for the Study of Obesity. October 29-November 2, 2000. Long Beach, California, USA. Abstracts. Obes Res. 2000; 8 Suppl 1:1S-138S. View

14.

Mutch D, Berger A, Mansourian R, Rytz A, Roberts M . The limit fold change model: a practical approach for selecting differentially expressed genes from microarray data. BMC Bioinformatics. 2002; 3:17. PMC: 117238. DOI: 10.1186/1471-2105-3-17. View

15.

Mokdad A, Marks J, Stroup D, Gerberding J . Correction: actual causes of death in the United States, 2000. JAMA. 2005; 293(3):293-4. DOI: 10.1001/jama.293.3.293. View

16.

Brody F, Hill S, Celenski S, Kar R, Kluk B, Pinzone J . Expression of ectonucleotide pyrophosphate phosphodiesterase and peroxisome proliferator activated receptor gamma in morbidly obese patients. Surg Endosc. 2007; 21(6):941-4. DOI: 10.1007/s00464-006-9098-3. View